ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $186,710 | +159.3% | 8,640 | +132.9% | 0.00% | – |
| Q3 2022 | $72,000 | -78.0% | 3,710 | -66.2% | 0.00% | -100.0% |
| Q1 2022 | $327,000 | +1321.7% | 10,975 | +1032.6% | 0.00% | – |
| Q4 2021 | $23,000 | -90.3% | 969 | -86.4% | 0.00% | -100.0% |
| Q3 2020 | $238,000 | +23700.0% | 7,129 | +27319.2% | 0.00% | – |
| Q2 2020 | $1,000 | -99.3% | 26 | -99.7% | 0.00% | -100.0% |
| Q1 2020 | $135,000 | +1587.5% | 8,255 | +1889.2% | 0.00% | – |
| Q3 2019 | $8,000 | -66.7% | 415 | -45.3% | 0.00% | – |
| Q2 2019 | $24,000 | – | 759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 491,244 | $9,510,000 | 5.10% |
| Decheng Capital Management III (Cayman), LLC | 623,342 | $12,068,000 | 4.38% |
| TANG CAPITAL MANAGEMENT LLC | 1,099,516 | $21,287,000 | 2.61% |
| Privium Fund Management B.V. | 300,252 | $5,624,000 | 2.04% |
| Birchview Capital, LP | 117,000 | $2,265,000 | 1.60% |
| Perceptive Advisors | 2,360,139 | $45,692,000 | 1.33% |
| Chicago Capital, LLC | 1,119,774 | $21,679,000 | 1.25% |
| Endurant Capital Management LP | 172,621 | $3,342,000 | 1.09% |
| Deep Track Capital, LP | 1,110,624 | $21,502,000 | 0.98% |
| SPHERA FUNDS MANAGEMENT LTD. | 359,000 | $6,950,000 | 0.96% |